0B68 Kim, Lyndon J. - Thomas Jefferson University - Thomas Jefferson University
Dr. Kim

Lyndon J. Kim, MD

Contact Dr. Kim

900 Walnut Street
Suite 200
Philadelphia, PA 19107

(215) 955-7000

Most Recent Peer-reviewed Publications

  1. Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: Prognosis and identification by 111indium-octreotide imaging
  2. Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas
  3. A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas
  4. A phase I trial of enzastaurin in patients with recurrent gliomas
  5. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma
  6. Erratum: Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme (Journal of Neuro-Oncology (2008) vol. 89 (339-357) 10.1007/s11060-008-9615-4)
  7. Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme
  8. A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors
  9. Chemotherapeutic options for primary brain tumors
  10. Neoplastic meningitis.
  11. Lipid-associated sialoprotein in the cerebrospinal fluid: Association with brain malignancies
  12. White-matter abnormalities in unirradiated patients cured of primary central nervous system lymphoma
  13. Concurrent chemotherapy and radiotherapy in patients with brain tumors
  14. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors
  15. Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants
  16. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas
0